Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Avalo Therapeutics (AVTX) Inventory Average (2018 - 2023)

Historic Inventory Average for Avalo Therapeutics (AVTX) over the last 6 years, with Q2 2023 value amounting to $18500.0.

  • Avalo Therapeutics' Inventory Average fell 2291.67% to $18500.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $18500.0, marking a year-over-year decrease of 2291.67%. This contributed to the annual value of $29000.0 for FY2022, which is 4146.34% up from last year.
  • Avalo Therapeutics' Inventory Average amounted to $18500.0 in Q2 2023, which was down 2291.67% from $19500.0 recorded in Q1 2023.
  • In the past 5 years, Avalo Therapeutics' Inventory Average registered a high of $682452.5 during Q1 2019, and its lowest value of $6030.0 during Q4 2020.
  • For the 5-year period, Avalo Therapeutics' Inventory Average averaged around $80425.1, with its median value being $20250.0 (2022).
  • As far as peak fluctuations go, Avalo Therapeutics' Inventory Average crashed by 9724.45% in 2020, and later surged by 34776.12% in 2021.
  • Over the past 5 years, Avalo Therapeutics' Inventory Average (Quarter) stood at $211800.5 in 2019, then tumbled by 97.15% to $6030.0 in 2020, then soared by 347.76% to $27000.0 in 2021, then decreased by 22.22% to $21000.0 in 2022, then fell by 11.9% to $18500.0 in 2023.
  • Its last three reported values are $18500.0 in Q2 2023, $19500.0 for Q1 2023, and $21000.0 during Q4 2022.